AeroLeads people directory · profile

Bobak Azamian, Md, Phd Email & Phone Number

President and CEO at Tarsus Pharmaceuticals, Inc.
Location: Irvine, California, United States 15 work roles 3 schools
1 work email found @tarsusrx.com LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email b****@tarsusrx.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
President and CEO
Location
Irvine, California, United States
Company size

Who is Bobak Azamian, Md, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Bobak Azamian, Md, Phd is listed as President and CEO at Tarsus Pharmaceuticals, Inc., a with 367 employees, based in Irvine, California, United States. AeroLeads shows a work email signal at tarsusrx.com and a matched LinkedIn profile for Bobak Azamian, Md, Phd.

Bobak Azamian, Md, Phd previously worked as Chairman at Tarsus Pharmaceuticals, Inc. and Chair of the Board at Osanni Bio. Bobak Azamian, Md, Phd holds Doctor Of Medicine (Md) from Harvard Medical School.

Company email context

Email format at Tarsus Pharmaceuticals, Inc.

This section adds company-level context without repeating Bobak Azamian, Md, Phd's masked contact details.

*@tarsusrx.com
71% confidence

AeroLeads found 1 current-domain work email signal for Bobak Azamian, Md, Phd. Compare company email patterns before reaching out.

Profile bio

About Bobak Azamian, Md, Phd

Bobby is the co-founder, CEO and Chairman of Tarsus Pharmaceuticals, a company dedicated to category creating medicines, starting with eye care. He is a physician, scientist, entrepreneur and biopharma leader with experience building and scaling healthcare companies designed to improve human health. Since its founding in 2016, Bobby has led Tarsus through a successful IPO, raised more than $500 million in private and public financings, established global partnerships and built a dynamic, award-winning culture. In 2023, the Company launched XDEMVY®, the first and only FDA approved treatment for Demodex blepharitis, a pervasive and damaging eyelid disease that affects ~25 million Americans. In parallel, Tarsus is continuing to advance a robust pipeline of product candidates that have the potential to create new categories in other therapeutic areas with high unmet need, including meibomian gland disease, rosacea and Lyme disease prevention.Bobby trained as a physician scientist, completing his residency in internal medicine and serving as an attending hospitalist at Brigham and Women’s Hospital. He received an MD from Harvard Medical School (Harvard-MIT Health Sciences and Technology), a PhD in chemistry from Oxford University as a Rhodes Scholar, and a BA in physics from Rice University.He began his biotechnology career at Versant Ventures and Third Rock Ventures, where he was an investor and board observer for a variety of life sciences companies. He later cofounded and led other novel therapeutics companies, including Vibrato Medical and Metavention. He currently serves as Chairman of the Board for Osanni Bio and as a Board member for Vibrato Medical.

Listed skills include Lifesciences, Biotechnology, Medical Devices, Life Sciences, and 29 others.

Current workplace

Bobak Azamian, Md, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc.
President and CEO
Irvine, CA, US
Website
Employees
367
AeroLeads page
15 roles

Bobak Azamian, Md, Phd work experience

A career timeline built from the work history available for this profile.

President And Ceo

Current

Irvine, California, Us

Co-founded November 2016 with Michael Ackermann, PhD

Sep 2018 - Present

Chair Of The Board

Current
Mar 2023 - Present

Co-Chair

Irvine, California, Us

Co-founded December 2016 with Babak Nazer, MD. Secured IP, obtained $2M NIH SBIR funding, assembled R&D team that developed clinic ready wearable therapeutic ultrasound system, and obtained clinical POC. Recruited full time CEO and supported $5M Series A raise and continued as Board member.

Sep 2019 - Dec 2022

Leadership Council Member

Current
Uci Edwards Lifesciences Foundation, Cardiovascular Innovation And Research Center (Circ)

Advisory board member of an academic-based research and training center housed within the Henry Samueli School of Engineering at the University of California, Irvine that aims to accelerate advances in cardiovascular health and health equity.

Jan 2012 - Present

Board Member

Newport Beach, Ca, Us

Board member of nonprofit accelerator to catalyze company creation and advancement in Orange County. Member of medtech and ophthalmology committees. Actively participated in planning, support, and speaking at key conferences Medtech Innovation Forum and Ophthalmology Technology Summit.

Jun 2012 - May 2021

President And Cmo

Maple Grove, Minnesota, Us

Co-founded June 2012 with Scott Vafai, MD, to develop novel neuromodulation treatments for cardiometabolic diseases. As founding CEO, established company, conceived approach, obtained issued patents, developed initial business plan, secured $3M Series A funding from Versant Ventures, and led R&D team that developed ablation catheter system and obtained positive preclinical POC. Then served as President and CMO and partnered with new CEO to secure $20M Series B funding led by large medtech company, and led clinical development through successful FIH dose-ranging studies in 50 patients in New Zealand. Finally served as interim CEO to close $65M Series B led by NEA and recruited new CEO before resigning to join Tarsus as CEO.

Sep 2013 - Sep 2018

Investment Professional

San Francisco, Ca, Us

Founding CEO of Metavention. Investments and board observer in Inceptus Medical, Sequent Medical, Intersection Medical, Sympara Medical.

Aug 2011 - Sep 2013

Senior Associate

Boston, Ma, Us

Focus on medical device investing and company creation. Investments and board observer in Corvia Medical, TARIS Biomedical, Coridea, NinePoint Medical, Seventh Sense Biosystems.

Jul 2009 - Jul 2011

Consultant

Thousand Oaks, Ca, Us

Sourced and evaluated new drug screening technologies in microfluidics and nanotechnology for potential licensing and partnerships.

Jun 2003 - Aug 2003
Team & coworkers

Colleagues at Tarsus Pharmaceuticals, Inc.

Other employees you can reach at tarsusrx.com. View company contacts for 367 employees →

3 education records

Bobak Azamian, Md, Phd education

Doctor Of Medicine (Md)

Harvard Medical School

Doctor Of Philosophy (Phd), Chemistry

University Of Oxford

Ba, Physics (Biophysics)

Rice University
FAQ

Frequently asked questions about Bobak Azamian, Md, Phd

Quick answers generated from the profile data available on this page.

What company does Bobak Azamian, Md, Phd work for?

Bobak Azamian, Md, Phd works for Tarsus Pharmaceuticals, Inc..

What is Bobak Azamian, Md, Phd's role at Tarsus Pharmaceuticals, Inc.?

Bobak Azamian, Md, Phd is listed as President and CEO at Tarsus Pharmaceuticals, Inc..

What is Bobak Azamian, Md, Phd's email address?

AeroLeads has found 1 work email signal at @tarsusrx.com for Bobak Azamian, Md, Phd at Tarsus Pharmaceuticals, Inc..

Where is Bobak Azamian, Md, Phd based?

Bobak Azamian, Md, Phd is based in Irvine, California, United States while working with Tarsus Pharmaceuticals, Inc..

What companies has Bobak Azamian, Md, Phd worked for?

Bobak Azamian, Md, Phd has worked for Tarsus Pharmaceuticals, Inc., Osanni Bio, Vibrato Medical, Inc., Uci Edwards Lifesciences Foundation, Cardiovascular Innovation And Research Center (Circ), and Octane Oc.

Who are Bobak Azamian, Md, Phd's colleagues at Tarsus Pharmaceuticals, Inc.?

Bobak Azamian, Md, Phd's colleagues at Tarsus Pharmaceuticals, Inc. include Golroxan (Roxan) Shoa, Janette Rodriguez, Tyler Plata, Jeff W., and Matthew Bright.

How can I contact Bobak Azamian, Md, Phd?

You can use AeroLeads to view verified contact signals for Bobak Azamian, Md, Phd at Tarsus Pharmaceuticals, Inc., including work email, phone, and LinkedIn data when available.

What schools did Bobak Azamian, Md, Phd attend?

Bobak Azamian, Md, Phd holds Doctor Of Medicine (Md) from Harvard Medical School.

What skills is Bobak Azamian, Md, Phd known for?

Bobak Azamian, Md, Phd is listed with skills including Lifesciences, Biotechnology, Medical Devices, Life Sciences, Venture Capital, Clinical Research, Healthcare, and Start Ups.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.